Cancer Trends in Iraq 2000-2016.
Cancer
Incidence
Iraq
Trend
Journal
Oman medical journal
ISSN: 1999-768X
Titre abrégé: Oman Med J
Pays: Oman
ID NLM: 101526350
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
07
02
2020
accepted:
13
07
2020
entrez:
8
2
2021
pubmed:
9
2
2021
medline:
9
2
2021
Statut:
epublish
Résumé
Precise and quantitative assessment of the trend of cancer burden enables policymakers and health managers to prioritize diseases and allocate resources better. This infers what caused a decrease or increase in the rate of cancer occurrence, and if it denotes timing of implementation of a control measure, it presents the impact on the disease rate. This study's objective was to evaluate trends in child and adult cancer in Iraq from 2000 onwards. We used the registries of the Iraqi Ministry of Health that were gathered from all governorates from 2000-2016. Data were presented as incidence rates to depict the trends of different types of cancers distributed by age, gender, and governorates. Breast cancer witnessed a significant increase with predominance in females. Lung cancer rate increased significantly from 4.08 to 5.60/100 000 ( Almost all cancers (particularly lung and gastrointestinal) showed constantly raising trends, especially after 2007. Only cervical and laryngeal cancer had a decreasing trend. Most cancers were predominant in males.
Identifiants
pubmed: 33552559
doi: 10.5001/omj.2021.18
pii: OMJ-36-01-2000020
pmc: PMC7847549
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e219Informations de copyright
The OMJ is Published Bimonthly and Copyrighted 2021 by the OMSB.
Références
Glob J Health Sci. 2015 May 17;8(1):189-93
pubmed: 26234980
Oman Med J. 2019 Jul;34(4):361-387
pubmed: 31360330
Asian Pac J Cancer Prev. 2015;16(13):5459-62
pubmed: 26225694
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
pubmed: 21296855
Asian Pac J Cancer Prev. 2015;16(17):7759-63
pubmed: 26625794
Curr Gastroenterol Rep. 2017 Aug;19(8):36
pubmed: 28730504
J BUON. 2016 Jul-Aug;21(4):994-1004
pubmed: 27685925
Med Confl Surviv. 2019 Sep;35(3):209-226
pubmed: 31597450
Asian Pac J Cancer Prev. 2013;14(6):3527-34
pubmed: 23886140
Asian Pac J Cancer Prev. 2016;17(1):407-12
pubmed: 26838247
Front Genet. 2012 Nov 28;3:268
pubmed: 23226157
BJU Int. 2011 Sep;108(6):806-13
pubmed: 21884356
Iran J Public Health. 2017 Aug;46(8):1145-1146
pubmed: 28894720
Breast Cancer (Dove Med Press). 2013 Oct 17;5:103-9
pubmed: 24648763
Asian Pac J Cancer Prev. 2016;17(2):839-43
pubmed: 26925689
J Oncol. 2017;2017:6827384
pubmed: 28932241
Int J Cancer. 2015 May 1;136(9):2187-95
pubmed: 25284703
Saudi Med J. 2014 Jul;35(7):674-83
pubmed: 25028223
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
JAMA Oncol. 2015 Jul;1(4):505-27
pubmed: 26181261
Lancet. 2016 Oct 8;388(10053):1545-1602
pubmed: 27733282
Asian Pac J Cancer Prev. 2015;16(16):7365-74
pubmed: 26514538
Jpn J Clin Oncol. 2014 May;44(5):401-7
pubmed: 24755545
Med Confl Surviv. 2013 Jan-Mar;29(1):7-25
pubmed: 23729095
PLoS One. 2013 Aug 14;8(8):e69951
pubmed: 23967065
Asian Pac J Cancer Prev. 2016;17(3):1393-7
pubmed: 27039778
Asian Pac J Cancer Prev. 2011;12(1):17-34
pubmed: 21517227
Cancer Epidemiol. 2015 Aug;39(4):519-27
pubmed: 26070507
Iran J Public Health. 2015 Sep;44(9):1225-33
pubmed: 26587497
Eur Urol. 2016 Nov;70(5):862-874
pubmed: 27289567
Gut. 2017 Apr;66(4):683-691
pubmed: 26818619
Popul Health Metr. 2014 Mar 04;12(1):4
pubmed: 24593777
Asian Pac J Cancer Prev. 2014;15(21):9125-30
pubmed: 25422189
JAMA Oncol. 2017 Apr 1;3(4):524-548
pubmed: 27918777
Oman Med J. 2011 Jul;26(4):258-62
pubmed: 22043430
Ethiop J Health Sci. 2016 May;26(3):199-200
pubmed: 27358539
Asian Pac J Cancer Prev. ;18(9):2437-2444
pubmed: 28952273
Neuro Oncol. 2015 May;17(5):747-56
pubmed: 25422316